EUVIMEDEUVIMED entdecken
Crossref

L26/P-698 Granulosa cells in polycystic ovary syndrome acquire a low-energy, anti-angiogenic phenotype with follicle-stage-specific DNA methyltransferase dysregulation

T.H. Lai, K.J. Hong, J.J. Lin

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T.H. Lai und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do granulosa cells (GC) in polycystic ovary syndrome (PCOS) show follicle-stage-specific metabolic and angiogenic dysfunction linked to DNA methyltransferase (DNMT) expression? Summary answer PCOS GCs show reduced growth and ATP, impaired pro-angiogenic paracrine effects, and follicle-size-dependent DNMT shifts consistent with epigenetic repression. What is known already PCOS is characterized by follicular arrest and suboptimal oocyte competence despite abundant follicles. Granulosa cell dysfunction, oxidative stress, and disturbed angiogenic signaling have all been implicated, yet the direction and cellular source of angiogenic abnormalities remain debated. Epigenetic mechanisms, including altered DNA methylation machinery, are increasingly recognized in PCOS pathophysiology, but how DNMT dysregulation relates to GC energy metabolism and angiogenic capacity across follicular growth stages is unclear. Study design, size, duration IRB approval was obtained, and all provided written informed consent. From Aug 2025 to Jan 2026, 63 women in their first IVF cycles were enrolled in a medical center: 31 with PCOS (Rotterdam) and 32 age- and BMI-matched ovulatory controls with male-factor, tubal, uterine, or unexplained infertility. Exclusions were endometrioma, ovarian cysts/tumors, malignancy, prior retrieval, non–GnRH antagonist protocols, AMH < 1.1 ng/mL, or poor response (< 3 oocytes). Clinical data were collected pre- and post-IVF. Participants/materials, setting, methods All participants underwent GnRH-antagonist IVF. Follicular aspirates at oocyte retrieval were stratified by follicle size and PCOS status (≥18 vs < 14 mm), and GCs were isolated. GC proliferation (CCK-8), angiogenic support (HUVEC tube formation with GC-conditioned media), mitochondrial function (Complex I activity), senescence (SA-β-gal), and angiogenesis-related transcripts (RT-qPCR) were assessed. Promoter methylation (bisulfite sequencing) and DNMT1/3A/3B/3L expression were quantified. Experiments were triplicated; Student’s t-test defined significance (p < 0.05). Main results and the role of chance Compared with controls, PCOS-derived granulosa cells (GCs) showed irregular morphology with enlarged cell size, reduced proliferation and passaging capacity, and decreased mitochondrial fluorescence with lower ATP generation, indicating compromised bioenergetic fitness. Functionally, conditioned media from large-follicle PCOS GCs impaired endothelial tube formation, suggesting weakened paracrine angiogenic support. In large follicles, PCOS GCs exhibited lower VEGF-A, CXCL6, GRO, IL-8, and MCP1 alongside higher PAI-1 (all p < 0.05), consistent with an anti-angiogenic, extracellular-matrix (ECM)-restrictive milieu. In small follicles, CXCL6, GRO, IL-8, and MCP1 were also reduced, whereas eotaxin was markedly increased; VEGF-A did not differ significantly, and PAI-1 was modestly downregulated (p < 0.05), supporting stage-dependent remodeling of chemokine-driven angiogenic signaling. Epigenetically, DNMT expression followed a reciprocal follicle-size pattern: DNMT1 and DNMT3A were upregulated in large PCOS follicles (p < 0.05), whereas DNMT3B increased in small PCOS follicles (p < 0.01) with lower DNMT1/3A (p < 0.05). Collectively, these findings suggest PCOS follicles progressively acquire a low-energy, anti-angiogenic, ECM-restrictive GC phenotype during maturation, plausibly linked to stage-specific DNMT dysregulation. This trajectory likely limits follicular oxygen and nutrient delivery and constrains cumulus expansion, undermining oocyte maturation and competence. Limitations, reasons for caution The sample size was relatively small, and outcome assessment relied primarily on in vitro functional readouts rather than clinical endpoints. Observed DNMT alterations were associative only; we did not conduct genome-wide methylation profiling, nor did we perform causal experiments to perturb DNMT activity and confirm mechanistic links in cell models. Wider implications of the findings Follicle-stage stratification uncovers a coherent metabolic–angiogenic–epigenetic signature in PCOS granulosa cells across distinct developmental stages. This integrative framework can inform biomarker discovery for oocyte competence, and it supports therapeutic targeting of metabolic-epigenetic crosstalk to normalize follicular vascular remodeling, enhance the microenvironment, and ultimately improve ART outcomes in PCOS patients. Trial registration number No

Zitieren

APA

Lai, T., Hong, K., & Lin, J. (2026). L26/P-698 Granulosa cells in polycystic ovary syndrome acquire a low-energy, anti-angiogenic phenotype with follicle-stage-specific DNA methyltransferase dysregulation. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1027

Vancouver

Lai T, Hong K, Lin J. L26/P-698 Granulosa cells in polycystic ovary syndrome acquire a low-energy, anti-angiogenic phenotype with follicle-stage-specific DNA methyltransferase dysregulation. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1027

BibTeX
@article{Lai2026,
  author = {Lai, T.H. and Hong, K.J. and Lin, J.J.},
  title = {L26/P-698 Granulosa cells in polycystic ovary syndrome acquire a low-energy, anti-angiogenic phenotype with follicle-stage-specific DNA methyltransferase dysregulation},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1027}
}
Kostenlos starten →